Blastic plasmacytoid dendritic cell neoplasia (BPDCN) is an aggressive hematologic malignancy originating from immature plasmacytoid dendritic cell (PDC) precursors. The initial manifestation of BPDCN often consists of cutaneous lesions. In this educational article, the clinical, histologic and therapeutic aspects of BPDCN are discussed from a dermatologic perspective.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- DERMATOLOGIE PRAXIS
Related Topics
You May Also Like
- Internal thoracoscopy
Diagnostic indications
- Rare pulmonary syndromes
Yellow nail and Swyer-James syndrome
- Follow-up care for head and neck cancer
What is the significance of FDG PET-CT?
- Important basics and studies on cancer and the psyche
Interplay between cancer and mental illness
- Systemic lupus erythematosus
Increased risk of pulmonary manifestations
- Postmenopausal osteoporosis: long-term therapy concepts
Targeted use of antiresorptives and osteoanabolic agents and avoid “rebound” effects
- Late-onset rheumatoid arthritis
More DMARDs can reduce glucocorticoids in LORA
- Atopic dermatitis